Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
CUV Announcements
CLINUVEL - injectable peptide platform…
CUV
CLINUVEL PHARMACEUTICALS LIMITED
Market sensitive
CLINUVEL - injectable peptide platform in preclinical study
Date and time
12 January 2026 at 7:42 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
CUV announcement history
Recent CUV announcements
CLINUVEL Annual Results - Investor Webinar
Becoming a substantial holder
CLINUVEL's injectable peptide platform
Commercial update on vitiligo
Update - SCENESSE in vitiligo
Notification of cessation of securities - CUV